These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 12577277

  • 1. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Müller-Oerlinghausen B, Bauer M.
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [Abstract] [Full Text] [Related]

  • 2. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M.
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [Abstract] [Full Text] [Related]

  • 3. Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity.
    Adli M, Bschor T, Bauer M, Lucka C, Lewitzka U, Ising M, Uhr M, Mueller-Oerlinghausen B, Baethge C.
    Neuropsychobiology; 2009 Nov; 60(1):23-30. PubMed ID: 19684420
    [Abstract] [Full Text] [Related]

  • 4. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [Abstract] [Full Text] [Related]

  • 5. Hypothalamic-pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major depression.
    Bschor T, Baethge C, Adli M, Lewitzka U, Eichmann U, Bauer M.
    J Psychiatry Neurosci; 2003 May; 28(3):210-6. PubMed ID: 12790161
    [Abstract] [Full Text] [Related]

  • 6. Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression.
    Bschor T, Adli M, Baethge C, Eichmann U, Ising M, Uhr M, Modell S, Künzel H, Müller-Oerlinghausen B, Bauer M.
    Neuropsychopharmacology; 2002 Sep; 27(3):470-8. PubMed ID: 12225704
    [Abstract] [Full Text] [Related]

  • 7. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R, Hubain P, Dramaix M, Mendlewicz J, Linkowski P.
    Encephale; 2002 Sep; 28(1):51-8. PubMed ID: 11963343
    [Abstract] [Full Text] [Related]

  • 8. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

  • 10. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients.
    Jokinen J, Nordström P.
    J Affect Disord; 2009 Jul; 116(1-2):88-92. PubMed ID: 19054568
    [Abstract] [Full Text] [Related]

  • 11. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F.
    Biol Psychiatry; 2007 Jul 01; 62(1):47-54. PubMed ID: 17123470
    [Abstract] [Full Text] [Related]

  • 12. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr 01; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 13. Increased adrenocorticotropin suppression following dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder.
    Duval F, Crocq MA, Guillon MS, Mokrani MC, Monreal J, Bailey P, Macher JP.
    Psychoneuroendocrinology; 2004 Nov 01; 29(10):1281-9. PubMed ID: 15288707
    [Abstract] [Full Text] [Related]

  • 14. Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients.
    Bschor T, Ising M, Erbe S, Winkelmann P, Ritter D, Uhr M, Lewitzka U.
    J Psychiatr Res; 2012 Jan 01; 46(1):111-7. PubMed ID: 22030468
    [Abstract] [Full Text] [Related]

  • 15. The impact of treatment on HPA axis activity in unipolar major depression.
    McKay MS, Zakzanis KK.
    J Psychiatr Res; 2010 Feb 01; 44(3):183-92. PubMed ID: 19747693
    [Abstract] [Full Text] [Related]

  • 16. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE, Ettigi P.
    Clin Pharm; 1983 Feb 01; 2(6):538-45. PubMed ID: 6140096
    [Abstract] [Full Text] [Related]

  • 17. The dexamethasone suppression test and response to somatic treatment: a review.
    Gitlin MJ, Gerner RH.
    J Clin Psychiatry; 1986 Jan 01; 47(1):16-21. PubMed ID: 3510195
    [Abstract] [Full Text] [Related]

  • 18. Gastrointestinal symptoms are associated with hypothalamic-pituitary-adrenal axis suppression in healthy individuals.
    Karling P, Norrback KF, Adolfsson R, Danielsson A.
    Scand J Gastroenterol; 2007 Nov 01; 42(11):1294-301. PubMed ID: 17852841
    [Abstract] [Full Text] [Related]

  • 19. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
    Schüle C, Baghai TC, Eser D, Nothdurfter C, Rupprecht R.
    World J Biol Psychiatry; 2009 Nov 01; 10(4 Pt 2):390-9. PubMed ID: 18609420
    [Abstract] [Full Text] [Related]

  • 20. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
    Rybakowski J, Linka M, Matkowski K, Kanarkowski R.
    Psychiatr Pol; 1991 Nov 01; 25(5):9-15. PubMed ID: 1821997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.